[{"orgOrder":0,"company":"Europharma","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Musculoskeletal","country":"U.S.A","productType":"Other Small Molecule","year":"2023","type":"Inapplicable","leadProduct":"2ccPA","moa":"Lysophosphatidic acid receptor","graph1":"Musculoskeletal","graph2":"Phase I\/ Phase II","graph3":"Europharma","amount2":0,"highestDevelopmentShortName":"Ph I\/II","therapeuticAreaShortName":"Musculoskeletal","amount2New":0,"dosageForm":"Intra-articular","sponsorNew":"Europharma \/ Inapplicable","highestDevelopmentStatusID":"7","companyTruncated":"Europharma \/ Inapplicable"},{"orgOrder":0,"company":"Europharma","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Musculoskeletal","country":"U.S.A","productType":"Other Small Molecule","year":"2020","type":"Inapplicable","leadProduct":"2ccPA","moa":"Lysophosphatidic acid receptor","graph1":"Musculoskeletal","graph2":"Phase I\/ Phase II","graph3":"Europharma","amount2":0,"highestDevelopmentShortName":"Ph I\/II","therapeuticAreaShortName":"Musculoskeletal","amount2New":0,"dosageForm":"Intra-articular","sponsorNew":"Europharma \/ Inapplicable","highestDevelopmentStatusID":"7","companyTruncated":"Europharma \/ Inapplicable"},{"orgOrder":0,"company":"Europharma","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Musculoskeletal","country":"U.S.A","productType":"Undisclosed","year":"2020","type":"Inapplicable","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Musculoskeletal","graph2":"Undisclosed","graph3":"Europharma","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Musculoskeletal","amount2New":0,"dosageForm":"Oral Powder","sponsorNew":"Europharma \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Europharma \/ Inapplicable"},{"orgOrder":0,"company":"Europharma","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"U.S.A","productType":"Other Small Molecule","year":"2020","type":"Inapplicable","leadProduct":"Mitiglinide Calcium","moa":"Sulfonylurea receptor 1, Kir6.2","graph1":"Endocrinology","graph2":"Phase IV","graph3":"Europharma","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Europharma \/ Inapplicable","highestDevelopmentStatusID":"11","companyTruncated":"Europharma \/ Inapplicable"},{"orgOrder":0,"company":"Europharma","sponsor":"Center of Drug and Medical Technologies Expertise, Armenia | Cardiomed LLC | Institute of Fine Organic Chemistry of the National Academy of Science, Armenia | Phytomed AB","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"U.S.A","productType":"Plant Extract\/Herbal","year":"2021","type":"Inapplicable","leadProduct":"Berberine","moa":"Telomerase reverse transcriptase (TERT)","graph1":"Undisclosed","graph2":"Phase I","graph3":"Europharma","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Europharma \/ Center of Drug and Medical Technologies Expertise, Armenia | Cardiomed LLC | Institute of Fine Organic Chemistry of the National Academy of Science, Armenia | Phytomed AB","highestDevelopmentStatusID":"6","companyTruncated":"Europharma \/ Center of Drug and Medical Technologies Expertise, Armenia | Cardiomed LLC | Institute of Fine Organic Chemistry of the National Academy of Science, Armenia | Phytomed AB"},{"orgOrder":0,"company":"Europharma","sponsor":"Phytomed AB | Center of Drug and Medical Technologies Expertise, Armenia | CARDIOMED Family Health Center, LLC of the Ministry of Health of Armenia | Institute of Fine Organic Chemistry of the National Academy of Science Yerevan, Armenia","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"U.S.A","productType":"Undisclosed","year":"2021","type":"Inapplicable","leadProduct":"Red Ginseng","moa":"Aryl hydrocarbon receptor; Interleukin-6; Prostaglandin G\/H synthase 2","graph1":"Undisclosed","graph2":"Phase I","graph3":"Europharma","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Europharma \/ Phytomed AB | Center of Drug and Medical Technologies Expertise, Armenia | CARDIOMED Family Health Center, LLC of the Ministry of Health of Armenia | Institute of Fine Organic Chemistry of the National Academy of Science Yerevan, Armenia","highestDevelopmentStatusID":"6","companyTruncated":"Europharma \/ Phytomed AB | Center of Drug and Medical Technologies Expertise, Armenia | CARDIOMED Family Health Center, LLC of the Ministry of Health of Armenia | Institute of Fine Organic Chemistry of the National Academy of Science Yerevan, Armenia"},{"orgOrder":0,"company":"Europharma","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Musculoskeletal","country":"U.S.A","productType":"Dietary Supplement","year":"2023","type":"Inapplicable","leadProduct":"Sarcojoint","moa":"Undisclosed","graph1":"Musculoskeletal","graph2":"Undisclosed","graph3":"Europharma","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Musculoskeletal","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Europharma \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Europharma \/ Inapplicable"}]

Find Clinical Drug Pipeline Developments & Deals by Europharma

Europharma
Drugs in Dev.
Full Screen View

Weekly News Recap
#Phispers

Stock Recap
#PipelineProspector

cayman pipeline prospector

Contact Supplier

Check all FDF Dossiers for
this supplier

Contact Us
PharmaScopic.com

Europharma

VISIT THE VIRTUAL BOOTH, Contact Details

DIGITAL CONTENT

Interview #SpeakPharma, Vlog #PharmaReel, Data Compilation #PharmaFlow, 1 News #PharmaBuzz

DEVELOPMENTS

21 Drugs in Development

21 Drugs in Development

FINISHED DOSAGE FORMULATIONS

33 FDF Dossiers, 33 Europe

Xls

Filters

×

filter

Company Name

filter

Year

filter

DEALS // DEV.

filter

Country

filter

Sponsor

filter

Therapeutic Area

filter

Study Phase

filter

Deal Type

filter

Product Type

filter

Dosage Form

filter

Lead Product

filter

Target

All Developments

Therapeutic Area by Lead Product

Study Phase by Lead Product

Company by Lead Product

Top Deals by Deal Size (USD bn)

Reset All

01

Europharma

U.S.A

Pharmaconex

Not Confirmed

02

Europharma

U.S.A

Pharmaconex

Not Confirmed

03

Europharma

U.S.A

Pharmaconex

Not Confirmed

04

Europharma

U.S.A

Pharmaconex

Not Confirmed

05

Europharma

U.S.A

Pharmaconex

Not Confirmed

06

Europharma

U.S.A

Pharmaconex

Not Confirmed

07

Europharma

U.S.A

Pharmaconex

Not Confirmed

08

Europharma

U.S.A

Pharmaconex

Not Confirmed

09

Europharma

U.S.A

Pharmaconex

Not Confirmed

10

Europharma

U.S.A

Pharmaconex

Not Confirmed

1
2
3